1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1994
-
Mark
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
(
- Contribution to journal › Article
- 1990
-
Mark
HER-2/neu amplification predicts poor survival in node-positive breast cancer
(
- Contribution to journal › Article
- 1989
-
Mark
HER2/neu amplification and comedo type breast carcinoma
(
- Contribution to journal › Letter